Veno-venous ECLS rescue for a heart transplant recipient with COVID-19, a case report

The potential for increased rates of morbidity of SARS-CoV-2 within immunocompromised populations has been of concern since the pandemic's onset. Transplant providers and patients can face particularly challenging situations, in the current settings as data continues to emerge for the prevention and treatment of the immunocompromised subpopulation. This case report details a patient 9-months post orthotopic heart transplant that developed SARS-CoV-2 infection despite two prior doses of the Pfizer-BioNtech COVID-19 vaccine, and had successful rescue from refractory hypoxemia with veno-venous extracorporeal membrane oxygenation (VV ECLS).

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:39

Enthalten in:

Perfusion - 39(2024), 3 vom: 25. März, Seite 631-634

Sprache:

Englisch

Beteiligte Personen:

Copeland, Hannah [VerfasserIn]
Baran, David A [VerfasserIn]
Morton, John [VerfasserIn]
Rodriguez, Vicente [VerfasserIn]
Fernandes, Eustace [VerfasserIn]
Mohammed, Asim [VerfasserIn]

Links:

Volltext

Themen:

Acute respiratory distress syndrome
BNT162 Vaccine
COVID-19
Case Reports
Extracorporeal life support
Extracorporeal membrane oxygenation
Heart transplant
Immunocompromised
Journal Article

Anmerkungen:

Date Completed 18.03.2024

Date Revised 18.03.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1177/02676591231154120

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM352258659